Pulmonx Corp reports results for the quarter ended in September - Earnings Summary

Pulmonx

30/10/2023 21:36

* Pulmonx Corp  LUNG.OQ  reported a quarterly adjusted loss
of 39
cents​​ per share for the quarter ended in September. The mean
expectation of six analysts for the quarter was for a loss of 43
cents per share.
    * Revenue rose 30.9% to $17.67 million from a year ago;
analysts
expected $16.39 million. 
    * Pulmonx Corp's reported EPS for the quarter was a loss
of 39
cents​.
    * The mean earnings estimate of analysts had risen by
about 4.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Pulmonx Corp shares had fallen by 20.4% this quarter and
lost 2.5% so far this year.
    * The company reported a quarterly loss of $14.9 million.
    * Wall Street's median 12-month price target for Pulmonx
Corp is
$16.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
October 30 at 09:36 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.43          -0.39          Beat
 Jun. 30 2023      -0.44          -0.43          Beat
 Mar. 31 2023      -0.44          -0.42          Beat
 Dec. 31 2022      -0.42          -0.38          Beat